Study Comparing Two Different Tablet Formulations Of Bosutinib

A Single Dose Bioequivalence Study Comparing the Commercial Tablet Formulation to the Clinical Tablet of Bosutinib in Healthy Subjects

This study is comparing 2 formulations of bosutinib in healthy subjects.

Inclusion Criteria:

• Men or women of non-childbearing potential, age 18 to 50 years.

Exclusion Criteria:

• Any significant cardiovascular, renal, hepatic, respiratory, gastrointestinal, endocrine, immunologic, dermatologic, hematologic, neurologic, or psychiatric disease.